Close Menu

NEW YORK – A new mathematical analysis suggests prostate cancer screening programs tailored to an individual's polygenic risk of the disease may catch disease and prevent deaths, while decreasing the overdiagnosis compared to age-based screening.

"Our study shows that targeted screening can reduce unnecessary diagnoses while helping to prevent people dying from the disease by enabling earlier detection," senior author Nora Pashayan, an applied health researcher at University College London, said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.